510(k) Report

FDA applicant

Ameditech, Inc.

San Diego, CA14 decisions2001–201187 recalls

FDA records 14 decisions for Ameditech, Inc. (San Diego, CA) from 2001 to 2011: 14 510(k) clearances. Most are in product codes DKZ (Enzyme Immunoassay, Amphetamine) and DJG (Enzyme Immunoassay, Opiates). Its devices cite 6 predicates, 6 of them its own earlier devices. 87 recalls are linked to its devices.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, clinical toxicology panel, where it files most

How often FDA has decided Ameditech, Inc.’s devices, and how often a recall has named them.

FDA decisions per year

2in 2011

2011: 2
2007high 2 (2011) · low 0 (2007)2026

2026 so far, outlined.

Recalls per year

3in 2020

2010: 12011: 22014: 32015: 782020: 3
2007high 78 (2015) · low 0 (2007)2026

Class I Class II/III not classified

FIG. 1 — Ameditech, Inc. by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Ameditech, Inc.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report